Tools for public health
Epi+ is a multi-hazard, open-source, event-based surveillance platform for EU/EEA countries that enables public health authorities to monitor, manage and respond to health events at the national level.
12829 results
This page includes the selection committees that have been appointed for the ongoing selection procedures.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 April 2026, and includes updates on avian influenza, dengue, and an overview of respiratory virus epidemiology in the EU/EEA.
Communicable disease threats report, 4-10 April 2026, Week 15
English (2.07 MB - PDF)
Infographic
Most respiratory virus activity remains low overall across the EU/EEA. Influenza and COVID 19 circulation are low or continuing to decline. RSV activity remains elevated, with early indications of a gradual decline.
News
ECDC, in partnership with the Africa Centres for Disease Control and Prevention (Africa CDC) and the Health Information Systems Program South Africa (HISP SA), are piloting a mobile application for event-based surveillance to enable the rapid collection and assessment of information about events that may signal a public health threat.
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 March-3 April 2026 and includes updates on SARS-CoV-2 variant classification, Middle East respiratory syndrome coronavirus (MERS-CoV), cholera, HIV, and avian influenza.
Communicable disease threats report, 28 March – 3 April 2026, Week 14
English (5.14 MB - PDF)
Risk assessment
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Risk assessment: Monkeypox multi-country outbreak
English (598.63 KB - PDF)
Public health guidance
Since 16 May 2022, and as of 4 April 2023, 21 170 cases of mpox (formerly known as monkeypox) have been reported by countries within the European Union/European Economic Area (EU/EEA).
Public health considerations for mpox in EUEEA countries 2023
English (3.93 MB - PDF)
Risk assessment
Since early May, and as of 11 October 2022, 20 455 confirmed cases of monkeypox (MPX) have been reported from 29 European Union/European Economic Area (EU/EEA) countries, including four deaths. As of 30 September, MPX confirmed cases reported from EU/EEA countries represented almost one third (29.7%) of the cases reported to the World Health Organization (WHO) globally (68 267 cases).
Monkeypox multi-country outbreak - second update
English (540.92 KB - PDF)
Risk assessment
Since early May 2022 and as of 7 July, cases of monkeypox (MPX) have been reported in non-endemic countries. Twenty-six European Union/European Economic Area (EU/EEA) countries have reported 4 908 cases, representing 65% of all cases reported worldwide in 2022.
Monkeypox multi-country outbreak - first update
English (1.09 MB - PDF)
Mpox (monkeypox) is a zoonotic viral disease caused by the Monkeypox virus (MPXV). The clinical presentation is similar to smallpox.
Update
ECDC together with the Latvian national authorities and the EU Health Task Force (EUHTF), completed an After-Action Review (AAR) to strengthen future preparedness and response to leptospirosis and other zoonotic disease outbreaks.
Update
On 17 March 2026, ECDC supported a simulation exercise in Brussels, Belgium, designed to explore cross-sectoral collaboration and coordination when responding to a potential viral haemorrhagic fever outbreak.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
ECDC cooperates with international partners, such as the World Health Organization and the centres for disease control and prevention (CDCs) across the globe.
ECDC monitors social media for epidemic intelligence purposes. This is done by monitoring a list of predefined users using Epidemic Intelligence from Open Sources (EIOS) and monitoring a list of predefined users on social media platforms.
The purpose of the Audit Committee is to assist the Management Board in fulfilling its oversight responsibilities for the financial reporting process, the system of internal control and the audit process.
Map
In 2026, there have been 32 729 CHIKVD cases and nine associated deaths reported worldwide.
Cases have decreased when compared to the same period in 2025.
Map
Since the beginning of 2026, and as of 23 March 2026, over 500 000 cases of dengue and over 100 dengue-related deaths had been reported globally, according to information from publicly available sources. This is a decrease compared to the same period in 2025.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, chikungunya, dengue, avian influenza, invasive meningococcal disease, aedes aegypti detection in Luxembourg, and measles.
Communicable disease threats report, 21 – 27 March 2026, Week 13
English (3.67 MB - PDF)
Data
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.